| # | Drug | Count |
|---|---|---|
| 0 | PACLITAXEL | 19 |
| 1 | FLUOROURACIL | 12 |
| 2 | FLUOROURACIL CREAM, 0.5% | 12 |
| 3 | OXALIPLATIN | 11 |
| 4 | PACLITAXEL (AIBUMIN-BOUND) | 10 |
| 5 | FUROSEMIDE | 7 |
| 6 | CARBOPLATIN | 6 |
| 7 | DOXORUBICIN | 6 |
| 8 | PEMBROLIZUMAB | 6 |
| 9 | TADALAFIL | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOXANTRONE HYDROCHLORIDE | 4 | 0.0006 |
| 1 | RYDAPT | 1 | 0.0005 |
| 2 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 3 | AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE | 1 | 0.0002 |
| 4 | COBIMETINIB | 1 | 0.0002 |
| 5 | PACLITAXEL | 19 | 0.0002 |
| 6 | SOTATERCEPT-CSRK | 1 | 0.0002 |
| 7 | FLUOROURACIL CREAM, 0.5% | 12 | 0.0002 |
| 8 | EPLERENONE | 2 | 0.0002 |
| 9 | FLUOROURACIL | 12 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Microtubule Inhibitor [EPC] | 19 | 0.0001 |
| 1 | Platinum-based Drug [EPC] | 17 | 0.0001 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 4 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 5 | Phosphodiesterase 5 Inhibitor [EPC] | 6 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 12 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 5 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |